91 results
8-K
GOSS
Gossamer Bio Inc
24 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
, the Company may appeal the Staff’s delisting determination to a Nasdaq Hearing Panel. There can be no assurance that, if the Company receives a delisting
8-K
EX-3.1
0q0cxekftv6ks30crbx
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
qemywg c69
20 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
424B3
mvdsvxu qv9
28 Aug 23
Prospectus supplement
4:29pm
S-3
0wm22y82zqnig7aom
18 Aug 23
Shelf registration
8:41am
S-3ASR
09r9h04y0822y
17 Aug 23
Automatic shelf registration
4:01pm
8-K
EX-10.1
m60 hb7w0
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm